BUCALO LOUIS R MD 4
4 · TITAN PHARMACEUTICALS INC · Filed Feb 9, 2005
Insider Transaction Report
Form 4
BUCALO LOUIS R MD
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2005-02-07+100,000→ 100,000 totalExercise: $2.62Exp: 2015-02-07→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Vests in two equal annual installments commencing one year from the date of grant.
- [F2]Not applicable.